The gauntlet of oncology trial planning, investigation, and final approval can be daunting. Oncology is the largest, fastest-growing, and most research-intensive therapeutic area in drug development, yet the need for new agents is urgent. Plus, cancer patients are among the hardest to recruit for clinical trials.
Innovations in personalized medicine are also creating a dynamic environment presenting increased requirements for scientific and operational expertise; access to high-performing investigator sites with the right patients; and global combinable data.
Your Innovative Solutions Begin Here
Covance understands the complexity of oncology—driven by rapid innovations in personalized care—and can partner with you to help navigate complex trial designs and conquer patient recruitment issues. With over 25 years of successful experience, we’ll help you meet your oncology challenges head-on and get your drug to patients who need it.
In the past five years alone, Covance has conducted over 1,000 oncology protocols; in over 141,000 patients; at 24,000-plus investigator sites; in 75 countries around the world. In fact, investigators name Covance as their “most preferred” central laboratory, more than twice as often as the nearest competitor.
Don’t let cancer trial complexity hinder you. Covance can help you remove obstacles with superior logistics, investigator rapport, and laboratory automation. We also create options with flexible and creative scientific expertise. And finally, we help you quicken the pace with fast access to data, enabling quicker informed decisions and speed to market.
Keep in mind that 47 out of the 50 best-selling oncology drugs of 2013 were developed in partnership with Covance. Let yours be next.
Click here for more information on our extensive and advanced menu of services; relentless commitment to data consistency; and best-in-class specimen processing, storage, and logistics.